Cognivue to Participate in Major Clinical Study with Global Alzheimer’s Platform
/
0 Comments
First FDA-cleared computerized test of cognitive function will be evaluated in the Bio-Hermes study; seeks to improve identification and screening…
Important Notice:
Cognivue has become aware of the unauthorized use of the Cognivue name by “CognivueAI” and cognivueaischool.com. Neither this organization nor its website is affiliated with, authorized by, or endorsed by Cognivue. If you receive related communications or experience unexpected charges, please contact us at support@cognivue.com or 585-433-2992.
Schedule a Cognivue DEMO Today ![]()

©2026 Cognivue, Inc. | Privacy Policy | References
